Gary Leatt is Director & 10% Owner at Acer Therapeutics Inc. (ACER). They have made 1 open-market trade across 1 company since 2017, most recently 2017-12-12.
CIK 0001718117
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.0M since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACER | 248,756 | $224K |
Shares reported on the most recent Form 4, priced at the 2018-01-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACER | BUY | 2017-12-12 | 2018-01-12 | $12.00 | $4.0M | +0.5% | -8.0% | -6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.